Why the study?
Does loss of NOX2 prevent oxidative stress and progression to advanced heart failure in a pressure-overload model?
Population
Human dilated cardiomyopathy samples and mice subjected to a pressure-overload model of advanced heart failure
Comparison
Loss of NOX2 (NOX2-deficient mice) vs Wild-type mice subjected to pressure overload
Design
Preclinical
Authors
Loading...
NOX2 merits further study as HF target; hypothesis-generating in animals and should not change practice.
Does loss of NOX2 prevent oxidative stress and progression to advanced heart failure in a pressure-overload model?
Loss of NOX2 prevents oxidative stress and adverse remodeling in pressure-overload heart failure, highlighting NOX2 as a potential therapeutic target.
Parajuli et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: